$290.22 -6.97 (-2.35%) Biogen Inc - NASDAQ

Dec. 5, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 290.22
Trade Time: Dec 05 04:00 PM Eastern Daylight Time
Change: -6.97 (-2.35%)
Prev Close: 297.19
Open: 298.94
Bid: 290.20
Ask: 290.22
  1. Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink

    TalkMarkets | Nov. 24, 2016 | 00:03AM EST
  2. Dow Jones Industrial Average Hits New Record In Afternoon Trading

    TalkMarkets | Nov. 23, 2016 | 22:16PM EST
  3. Paid To Wait? Eli Lilly Crashes To 2 Year Lows, Erases 6 Years Of Dividends After Failed Drug Test

    TalkMarkets | Nov. 23, 2016 | 10:21AM EST
  4. Morgan Stanley Expects Big Reversal Today In Biogen Shares

    TalkMarkets | Nov. 23, 2016 | 10:00AM EST
  5. Magic Recipe Movers - The Trump Effect

    TalkMarkets | Nov. 13, 2016 | 22:45PM EST
  6. On The Fly: Top stock stories for Monday

    TalkMarkets | Nov. 7, 2016 | 18:48PM EST
  7. Biogen Rises After Muscular Disorder Drug Data, Piper Upgrade

    TalkMarkets | Nov. 7, 2016 | 12:38PM EST
  8. Morning Call For Monday, Nov. 7

    TalkMarkets | Nov. 7, 2016 | 08:53AM EST
  9. Biogen Upgraded To Overweight From Neutral At Piper Jaffray

    TalkMarkets | Nov. 7, 2016 | 08:08AM EST
  10. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 18:49PM EST
  11. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets | Oct. 26, 2016 | 20:45PM EST
  12. Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates

    TalkMarkets | Oct. 26, 2016 | 14:15PM EST
  13. 5 Stocks To Watch Before The Market Opens Tomorrow (October 26, 2016)

    TalkMarkets | Oct. 25, 2016 | 16:20PM EST
  14. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets | Oct. 20, 2016 | 13:53PM EST
  15. Biotech Stock Roundup: Ariad Down On Drug Pricing Tweet, Regeneron Study On Clinical Hold

    TalkMarkets | Oct. 19, 2016 | 14:27PM EST
Trading Center